Back

Group Bont

About

The RSV Research Group has the vision to combine clinical and basic research to decrease the global burden of RSV infection. Our mission is to improve knowledge of RSV epidemiology, and to develop safe and effective therapeutic and preventive interventions. The RSV Research Group consists of clinician scientists and lab researchers focusing on the epidemiology and pathogenesis of RSV bronchiolitis. RSV infections cause a major burden for patients, their parents and society. RSV infection is the second most frequent cause of death during infancy, only malaria is associated with higher mortality.

Group members

Group Leaders

prof. dr. L.J. Bont Full Professor

prof. dr. L. Meyaard Full Professor

Senior researchers

Joanne Wildenbeest

Katrien Oude Rengerink

Technician

Margreet Westerlaken

PhD students

Koos Korsten

Natalie Mazur

Sjanna Besteman

Arthur van Stigt

Annefleur Langedijk

Yvette Lowensteyn

Roy Zuurbier

Marie Billard

Patient advisory board

Nicole Derksen-Lazet, lead Patient Advisory Board

Inge Oliemans, communication Patient Advisory Board

Research nurses

Loes Nibbelke

Brigitte Buiteman

ReSViNET Foundation

Leyla Kragten-Tabatabaie, Board of Directors ReSViNET Foundation

Key publications

  1. Blanken, M. O., et al. (2013). "Respiratory Syncytial Virus and Recurrent Wheeze in Healthy Preterm Infants." 368(19): 1791-1799.Blanken, M. O., et al. (2013). View
  2. Mazur, N. I., et al. (2015). "Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics." Lancet Respir Med 3(11): 888-900. View
  3. van Houten, C. B., et al. (2017). "A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study." Lancet Infect Dis 17(4): 431-440. View
  4. Scheltema, N. M., et al. (2018). "Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial." Lancet Respir Med 6(4): 257-264. View
  5. Mazur, N. I., et al. (2018). "The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates." Lancet Infect Dis 18(10): e295-e311. View

Marteen Blanken

2019

Chantal van Houten

2019

 

Nienke Scheltema
2018

Innate immunity in RSV infection

Tina Faber

2017

Grants


2017 - Respiratory Syncitial virus Consortium in Europe(RESCUE, IMI)

2016 - RSV GOLD (BMGF)

2014 - Longfonds Consortium Grant

Support our research

  • Resvinet foundation

Collaborations

RSV GOLD

funded by Bill and Melinda Gates Foundation

IMPRIND

for biomarker research to diagnose bacterial infection

ReSViNET Network

for RSV Research, chairman

TAILORED Network

for biomarker discovery of virus versus bacterial respiratory tract infection

RESCEU Network

for RSV Burden of Disease studies (funded by IMI/H2020)

RSV Society

under ISIRV

Education & Courses

  • International conference: RSVVW, Accra, Ghana
  • Summer school on Global Child Health, Utrecht

Research programs

Infection and Immunity

Child Health

Research interests/topics

Epidemiology and pathogenesis of RSV bronchiolitis

Contact

Related website